Colleen R. Kelly, MD, is a gastroenterologist in the Center for Women’s Gastrointestinal Medicine at the Women’s Medicine Collaborative. She is an assistant professor of medicine (clinical) at The Warren Alpert Medical School of Brown University and a faculty member in the fellowship pathway in women’s gastrointestinal diseases at Alpert Medical School. She received a medical degree from Ohio State University in Columbus, Ohio, completed a residency in internal medicine at Boston Medical Center, and completed a fellowship in gastroenterology at Alpert Medical School. She is a fellow of the American College of Gastroenterology.
Kelly has been an active participant in the Rhode Island Pelvic Floor Network and led the irritable bowel syndrome and motility effort at Women & Infants Hospital before moving to the Women’s Medicine Collaborative. She is nationally recognized in the field of gut flora and its implication in recurrent C. difficile infection. The focus of her research and clinical practice is fecal microbiota transplant (FMT) and she has assisted many physicians and institutions in developing FMT protocols.
Kelly has authored a number of papers and abstracts on the subject and was a member of a working group that drafted a best-practices article for treating C. difficile infection with FMT, published in 2011.
She is a principal investigator for the first US clinical trial of FMT to treat relapsing C. difficile infection, funded by the National Institutes of Health (NIDDK). She is on the board of advisors of The Fecal Transplant Foundation. Kelly is board certified in gastroenterology. Her clinical interests include fecal transplantation, C. difficile, chronic diarrhea and other gastrointestinal motility disorders common in women, such as constipation and irritable bowel syndrome.